GNPX · Genprex, Inc.
AI read · Good for GNPX
The AI's read
A marker that helps select patients could help Genprex match its treatment to those more likely to benefit. The study used lab models, not reported patient results. Genprex still expects to finish test validation by the end of 2026, and use in clinical programs remains a possibility.